Long term hodgkin ’s lymphoma survivors: a glimpse of what happens 10 years after treatment

This retrospective study was focused on 96 patients with HL treated between 2005 and 2008, in order to evaluate the outcome and the long-term mobility. After a median follow-up of 12 years, 85 patients (88%) are alive in CR and 11 (14%) have died (2 of a second neoplasia, 1 of infection, 8 of the disease).. Three women became pregnant and each gave birth to a healthy child. The most prevalent chronic conditions at last follow-up were: a reduction in DLCO (40%), fatigue (31%), hypothyroidism (30%), infertility (16%). The presence of a second neoplasm was documented in 4% of patients three DLBCLs were diagnosed at a median of 50 months after LH (range 38-100 months), two responded to treatment and are still in complete remission, one died of lymphoma. One patient with undifferentiated carcinoma died 30 months after the LH. The 140 months Kaplan-Meier survival estimates were 86%

Source: Clinical Lymphoma, Myeloma and Leukemia - March 18, 2020 Category: Hematology Authors: Filomena Emanuela Laddaga, Tommasina Perrone, Marco Moschetta, Sebastio Perrini, Paolo Colonna, Giuseppe Ingravallo, Dario D ’abbicco, Giorgina Specchia, Francesco Gaudio Tags: Original Study Source Type: research